Location History:
- Leverkusen, DE (2020 - 2021)
- Brieselang, DE (2020 - 2023)
Company Filing History:
Years Active: 2020-2023
Title: Patrick Billian: Innovator in Pharmaceutical Compositions
Introduction
Patrick Billian is a notable inventor based in Brieselang, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative liquid compositions and pharmaceutical preparations. With a total of five patents to his name, Billian's work has had a considerable impact on animal health.
Latest Patents
Among his latest patents is a liquid composition containing pradofloxacin. This invention relates to pharmaceutical compositions in liquid form that comprise pradofloxacin in an aqueous solution, along with citric acid or thioglycerol as antioxidants. Another significant patent is for a pharmaceutical preparation and method for its manufacture. This preparation includes a first pharmaceutical composition with a matrix material and pharmaceutically active ingredients, such as Praziquantel, Pyrantel, and Febantel. The preparation also features a second pharmaceutical composition with active ingredients like Moxidectin, structured in a multi-layer format to enhance efficacy.
Career Highlights
Throughout his career, Patrick Billian has worked with prominent companies in the pharmaceutical industry, including Bayer Animal Health GmbH and Elanco US Inc. His experience in these organizations has allowed him to refine his expertise in developing innovative solutions for animal health.
Collaborations
Billian has collaborated with notable professionals in his field, including Venkata-Rangarao Kanikanti and Hans-Juergen Hamann. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Patrick Billian's contributions to pharmaceutical innovations demonstrate his commitment to improving animal health through effective and novel compositions. His work continues to influence the industry and pave the way for future advancements.